Clinical Trial Update: Conversion From Fast Acting Oral Opioids to Abstral® [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating conversion from fast-acting oral opioids to Abstral for pain was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Abstral (fentanyl)

Snippet

Sponsor: Orexo AB | Conditions: Pain | Phase 4 | Status: TERMINATED